Presentation TCT 2019 Tackling Inflammation: Novel Targets Presenter: Wolfgang Koenig September 26, 2019
Presentation TCT 2019 Don’t Forget About Your HDL: The AEGIS Program Presenter: C. Michael Gibson September 26, 2019
Presentation TCT 2019 Role of PCSK9 Inhibitors Post-PCI and ACS Presenter: Marc Bonaca September 26, 2019
Presentation TCT 2019 Loading Dose Statin Prior PCI: Is There a Role For It? Presenter: Renato Lopes September 26, 2019
News Daily News CMR May Help Evaluate Nonculprit Lesions in STEMI Patients Todd Neale September 19, 2019
News Daily News MI Definitions in SCOT-HEART Prompt Outcry—Then Silence—on Twitter Shelley Wood September 19, 2019
News Daily News High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis L.A. McKeown September 13, 2019
News Daily News Greater Exposure to Toxins on 9/11 Left Firefighters at Increased Long-term CVD Risk L.A. McKeown September 11, 2019
News Conference News ESC 2019 GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS Yael L. Maxwell September 10, 2019
News Conference News ESC 2019 Young MI Patients’ Ischemic Risk Extends at Least Two Decades Caitlin E. Cox September 06, 2019
News Conference News ESC 2019 Stopped Early, DAPA Offers Insight on ICD Timing After STEMI Shelley Wood September 04, 2019
News Conference News ESC 2019 Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART Yael L. Maxwell September 04, 2019
News Conference News ESC 2019 For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI Todd Neale September 03, 2019
News Conference News ESC 2019 New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD Shelley Wood August 31, 2019
News Daily News Young Survivors of Childhood Cancer Have Higher, Earlier Risk of CVD Events L.A. McKeown August 30, 2019
News Daily News Artificial Intelligence Mines ECG Data to Estimate ‘Physiologic Age’ Yael L. Maxwell August 27, 2019
News Daily News Decline in US Deaths From CVD and Diabetes Is Leveling Off Todd Neale August 27, 2019
News Daily News Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES Michael O'Riordan August 26, 2019